Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. - Wikidata - wikimedia - TriplyDB

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

http://www.wikidata.org/entity/Q37742318

about

Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer Post-surgical chemotherapy versus surgery alone for resectable gastric cancer Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus LZTFL1 suppresses gastric cancer cell migration and invasion through regulating nuclear translocation of β-catenin Treatment of gastric cancer Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis Molecular mechanisms of peritoneal dissemination in gastric cancer Neoadjuvant therapy for gastroesophageal adenocarcinoma Current adjuvant treatment modalities for gastric cancer: From history to the future Advanced gastric cancer: What we know and what we still have to learn Neoadjuvant therapy for gastric cancer: current evidence and future directions Clinical utility of ramucirumab in advanced gastric cancer Neoadjuvant or adjuvant therapy for gastric cancer Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy Multimodal treatment of gastric cancer in the west: Where are we going?Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward Chemotherapy for patients with gastric cancer after complete resection: a network meta-analysis Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis Adjuvant therapy for gastric cancer: what have we learned since INT0116?Comparison of international guidelines on the accompanying therapy for advanced gastric cancer: reasons for the differences Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review Prognostic relevance of SAMSN1 expression in gastric cancer Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer.Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials Adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis.Adjuvant chemoradiotherapy versus chemotherapy for gastric cancer: a meta-analysis of randomized controlled trials.Effect of Clostridium perfringens enterotoxin on gastric cancer cells SGC7901 which highly expressed claudin-4 protein.Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial.Antitumor activity of cell-permeable RUNX3 protein in gastric cancer cells Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.Comments to young surgeons concerning laparoscopic spleen-preserving D2 lymph node dissection for advanced gastric cancer on the upper body.Prognostic significance of ERCC1 expression in postoperative patients with gastric cancer.Tumor and serum gamma-glutamyl transpeptidase, new prognostic and molecular interpretation of an old biomarker in gastric cancer.Genotypic and phenotypic characterization of side population of gastric cancer cell lines.Interpreting whole genome and exome sequencing data of individual gastric cancer samples.Adjuvant Chemotherapy with Docetaxel, Cisplatin, and Continuous-Infusion 5-Fluorouracil for Gastric Cancer: A Phase II Study.

P2860

Q24187903-103F80F1-4086-489C-8D6B-619D752009A8 Q24198252-5DBE5CF0-2B32-4C53-B307-A286D2659B1E Q24202230-03079FE8-D204-48CC-A9C8-DD2A3605546E Q24202957-3860FD49-66DF-4C3C-811F-6892810A3B55 Q24300514-1869ED4D-A935-4D67-B276-211862052807 Q24602875-8306832E-94CB-422B-A0BB-F89C5836C946 Q26738505-186D4E2D-3572-4D17-8E86-908EF3CD58D3 Q26738538-968749AC-677B-46E6-BFF4-54B78BA69DF0 Q26746147-8FEB01F0-B208-41C7-B937-8D4D33D7C0BC Q26748744-263B0EAD-B411-4282-B3B4-A8AB1201DADE Q26774528-686355C9-931B-4F98-8E8C-2086A1190C63 Q26781043-46796C2E-95F2-4298-A077-C7DF85CB8A7E Q26785665-A23B98BB-C6F9-43B7-9520-8627CD0C3FF3 Q26797427-E86DA780-46AF-49F4-BAF7-256A50DB7F46 Q26798420-B65ACA28-58F8-420E-9F28-AD8379433CBD Q26799748-79BCD46C-6AF1-49DB-8DCA-AA8D9243904B Q26800355-3B8B1521-6F41-4DAC-A949-731DFBBBB20A Q26828506-D216D3AF-459A-4DD9-8FD6-1937013799A6 Q26858776-9488B09F-A120-45D5-8A9C-7CCB1AFCBF57 Q26859950-781E9FB0-A26C-4A79-B79E-ABD86D17D8BE Q26860637-EFD19ECC-B046-4DA8-9C00-6200646CEA1B Q27008675-EB5AA154-BB6B-4A3A-907F-42BD9CF0FC4F Q28086772-01FB2C84-52DD-4F84-B627-231FFCE6D6E0 Q28088619-22224571-FFB7-4E1E-9884-5296E140026B Q30008786-A25C510A-25C0-420E-9619-A7BC0583C795 Q30248541-E75CE129-3374-4CB5-9D87-FE12D828D4AF Q31150068-F2B35E34-E7B2-420A-899A-011C1C420D46 Q33414608-16FE878A-62D2-4709-81F1-7E37AD8B220C Q33417940-DD90F1A6-BF53-4012-9CCF-8ECCCC215958 Q33560096-F08561C3-CE39-411B-9D38-3BBFD5EFE657 Q33649965-3EC6E5C2-3B99-475C-BE65-60B16740155D Q33690619-73E7F729-7FC7-41C7-8B65-9728BF2BA110 Q33755139-3732AFE7-A8F3-409D-A17A-E1B6534CF290 Q33761863-FCEC10F5-5A97-45D8-BA6B-1E237DA85038 Q33827368-CC8E950D-FE7A-46BB-8A1A-E918D15FC67B Q33827385-F7BCD1FD-0403-422E-9E48-60F150DD75EE Q33829437-ED39F6D0-C522-43CC-B318-BF51AD9464F2 Q33855045-767DB444-EB61-4E48-9C1B-943B75444A31 Q33882869-E78103D7-8387-48DE-8CB0-FB2BA589872D Q33912309-05617D2F-665F-43E4-AB2C-C64FDE2CE864

P2860

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

http://www.wikidata.org/entity/Q37742318

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

@en

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

@nl

type

label

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

@en

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

@nl

prefLabel

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

@en

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

@nl

P1433

Q37742318-4C226C62-15D6-4963-8DF2-12EF8D63301D

P1476

Q37742318-EAEF8BF8-1084-44DA-939F-395A44F92BE8

P2093

Q37742318-15309900-8C41-42E7-8B1C-8FFD1432B640

Q37742318-25466E65-E28F-49E7-B8B1-F2928ADCE371

Q37742318-503035DF-8517-45B5-A89B-9908432B371F

Q37742318-61CDCA97-951D-4265-9C41-43E3FBD70DFF

Q37742318-69C49E11-DAE9-4F67-A551-5A7359D64DAD

Q37742318-8F5DECBF-5E3B-42A3-8E7E-06AB76FBAB38

Q37742318-C6E353B0-76AA-496F-9D83-6AD41841F52D

P304

Q37742318-5D99F9B1-0470-484C-BE2E-824B1758E26A

P31

Q37742318-49ea5f64-6013-4516-b5d9-ca96941db9f1

Q37742318-FEDDF5D9-D5FC-4E2D-8D51-C471A7A18725

P356

Q37742318-DB13C22E-41EC-4AE7-967F-66CCA32F00BB

P407

Q37742318-7EEA9AA8-8BEA-49D9-9B9A-9CD96A2D43EA

P433

Q37742318-4D14E857-7769-46C9-BFD9-3E57EA235E9F

P478

Q37742318-BF109740-DC95-4519-B924-C9B3B1757898

P50

Q37742318-09F1DBA1-7EE0-4EE2-A09F-8A467BA8618B

Q37742318-31A79F16-2094-4D4A-93A0-CE390F7F1805

Q37742318-71CC38FA-80AC-437E-88AC-6EE099DBB96D

Q37742318-B864854B-6163-42CB-8CC9-43F526652093

Q37742318-BF96BA5B-4E32-42A6-B858-255E4088B77E

Q37742318-E901F39B-07E9-4375-BC1B-460C9C4E6FB1

P577

Q37742318-98BA7B4B-BB55-4E51-94EF-B80F6DBB58D2

P698

Q37742318-A61C4818-50CD-4E30-A3D0-DB888CE77540

P921

Q37742318-568FD269-6AE8-43AE-9571-D626042ADF5C

Q37742318-9362972B-2CEA-489B-9B96-7B69948B35EC

P356

P1433

Journal of the American Medical Association

P1476

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.

@en

P2093

Eric Van Cutsem

http://www.w3.org/2001/XMLSchema#string

GASTRIC (Global Advanced/Adjuv ...... rnational Collaboration) Group

http://www.w3.org/2001/XMLSchema#string

Junichi Sakamoto

http://www.w3.org/2001/XMLSchema#string

Mitsuru Sasako

http://www.w3.org/2001/XMLSchema#string

Philippe Rougier

http://www.w3.org/2001/XMLSchema#string

Xavier Paoletti

http://www.w3.org/2001/XMLSchema#string

Yasuo Ohashi

http://www.w3.org/2001/XMLSchema#string

P304

1729-1737

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2010.534

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

303

http://www.w3.org/2001/XMLSchema#string

P50

Stefan Michiels

Daniel J. Sargent

Jean-Pierre Pignon

Tomasz Burzykowski

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20442389

http://www.w3.org/2001/XMLSchema#string

P921